Tenaya Therapeutics GAAP EPS of -$0.08 beats by $0.02, revenue of $1.7M beats by $0.9M
Open the sourceReported by Seeking Alpha, seekingalpha.com, 4 November 2026
25Impact 25 of 100, routine
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.
Named in this story
Tenaya Therapeutics